Physician profile
Steven Wolf
NPI 1013980556
$1,844.86
in general payments reported to CMS, 2019-2025
26 companies · $15.42 in 2025
The $15.42 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $134 · 2021: $78.56 · 2022: $330 · 2023: $486 · 2024: $569 · 2025: $15.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $371.73 | 2019-2024 | Ubrelvy, Vraylar, Qulipta |
| Astellas Pharma US INC | $312.06 | 2022-2024 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $248.64 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $169.11 | 2023-2024 | Gemtesa, Myfembree |
| Therapeuticsmd, INC. | $83.15 | 2019-2022 | |
| Myovant Sciences INC. | $76.60 | 2021-2022 | |
| Pfizer INC. | $62.27 | 2020-2021 | |
| Ethicon US, LLC | $54.83 | 2023 | Dermabond, Ethicon, Dermabond Prineo |
| Boston Scientific Corporation | $43.65 | 2022-2025 | General - Erectile Dysfunction |
| Coloplast Corp | $36.57 | 2023-2024 | Altis |
| Daiichi Sankyo INC. | $36.09 | 2023-2024 | Injectafer |
| Monaghan Medical Corporation | $35.58 | 2024 | Aeroeclipse |
| Merck Sharp & Dohme LLC | $32.84 | 2019-2020 | |
| Baxter Healthcare | $29.76 | 2024 | Perclot |
| Exeltis, USA INC. | $29.68 | 2020-2023 | Slynd |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $27.98 | 2022-2024 | Myosure Tissue Removal Device |
| Allergan, INC. | $24.76 | 2019-2020 | |
| Northgate Technologies, INC. | $24.76 | 2024 | Stimsite |
| Organon LLC | $24.34 | 2024 | |
| Avion Pharmaceuticals | $22.06 | 2019 | |
| Medtronic, INC. | $18.44 | 2024 | Venaseal |
| Urovant Sciences INC | $18.26 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.10 | 2022 | |
| Shield Therapeutics INC | $17.71 | 2023 | Accrufer |
| Olympus America INC. | $14.26 | 2019 | |
| Minerva Surgical, INC | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.